Gilead Sciences Inc (GILD)
Debt-to-capital ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 19,330,000 | 22,833,000 | 21,209,000 | 21,064,000 | 18,221,000 |
| Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $19,330,000K)
= 0.00
Based on the provided data, Gilead Sciences Inc has consistently maintained a debt-to-capital ratio of 0.00 from December 31, 2020, to December 31, 2024. This indicates that the company has not taken on any debt relative to its capital structure during this period. A debt-to-capital ratio of 0.00 typically suggests that Gilead Sciences Inc has been funding its operations and investments primarily through equity financing rather than debt financing. This may indicate a strong financial position with lower financial risk associated with debt obligations. However, it's important to note that a zero debt-to-capital ratio may also imply that the company is not taking advantage of potential debt financing for growth or expansion opportunities.
Peer comparison
Dec 31, 2024